TCPA_HUMAN - dbPTM
TCPA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TCPA_HUMAN
UniProt AC P17987
Protein Name T-complex protein 1 subunit alpha
Gene Name TCP1
Organism Homo sapiens (Human).
Sequence Length 556
Subcellular Localization Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.
Protein Description Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin..
Protein Sequence MEGPLSVFGDRSTGETIRSQNVMAAASIANIVKSSLGPVGLDKMLVDDIGDVTITNDGATILKLLEVEHPAAKVLCELADLQDKEVGDGTTSVVIIAAELLKNADELVKQKIHPTSVISGYRLACKEAVRYINENLIVNTDELGRDCLINAAKTSMSSKIIGINGDFFANMVVDAVLAIKYTDIRGQPRYPVNSVNILKAHGRSQMESMLISGYALNCVVGSQGMPKRIVNAKIACLDFSLQKTKMKLGVQVVITDPEKLDQIRQRESDITKERIQKILATGANVILTTGGIDDMCLKYFVEAGAMAVRRVLKRDLKRIAKASGATILSTLANLEGEETFEAAMLGQAEEVVQERICDDELILIKNTKARTSASIILRGANDFMCDEMERSLHDALCVVKRVLESKSVVPGGGAVEAALSIYLENYATSMGSREQLAIAEFARSLLVIPNTLAVNAAQDSTDLVAKLRAFHNEAQVNPERKNLKWIGLDLSNGKPRDNKQAGVFEPTIVKVKSLKFATEAAITILRIDDLIKLHPESKDDKHGSYEDAVHSGALND
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEGPLSVF
-------CCCCCEEC
14.0019413330
1Sulfoxidation-------MEGPLSVF
-------CCCCCEEC
14.0028465586
6Phosphorylation--MEGPLSVFGDRST
--CCCCCEECCCCCC
20.6621406692
11MethylationPLSVFGDRSTGETIR
CCEECCCCCCCCCHH
36.18-
12PhosphorylationLSVFGDRSTGETIRS
CEECCCCCCCCCHHH
45.5723186163
13PhosphorylationSVFGDRSTGETIRSQ
EECCCCCCCCCHHHH
39.6723186163
19PhosphorylationSTGETIRSQNVMAAA
CCCCCHHHHHHHHHH
23.4320068231
23SulfoxidationTIRSQNVMAAASIAN
CHHHHHHHHHHHHHH
2.4921406390
27PhosphorylationQNVMAAASIANIVKS
HHHHHHHHHHHHHHH
19.9420068231
33UbiquitinationASIANIVKSSLGPVG
HHHHHHHHHCCCCCC
30.45-
34PhosphorylationSIANIVKSSLGPVGL
HHHHHHHHCCCCCCC
21.6521712546
35PhosphorylationIANIVKSSLGPVGLD
HHHHHHHCCCCCCCC
31.4621712546
43UbiquitinationLGPVGLDKMLVDDIG
CCCCCCCCCEECCCC
38.89-
44SulfoxidationGPVGLDKMLVDDIGD
CCCCCCCCEECCCCC
4.3830846556
55PhosphorylationDIGDVTITNDGATIL
CCCCEEEECCCCHHH
20.2125690035
60PhosphorylationTITNDGATILKLLEV
EEECCCCHHHHHHHC
32.1625690035
63UbiquitinationNDGATILKLLEVEHP
CCCCHHHHHHHCCCH
47.3721906983
73UbiquitinationEVEHPAAKVLCELAD
HCCCHHHHHHHHHHC
37.5321890473
732-HydroxyisobutyrylationEVEHPAAKVLCELAD
HCCCHHHHHHHHHHC
37.53-
73AcetylationEVEHPAAKVLCELAD
HCCCHHHHHHHHHHC
37.5327452117
76S-nitrosocysteineHPAAKVLCELADLQD
CHHHHHHHHHHCCCC
4.51-
76S-nitrosylationHPAAKVLCELADLQD
CHHHHHHHHHHCCCC
4.5122178444
84AcetylationELADLQDKEVGDGTT
HHHCCCCCCCCCCHH
41.147430915
90PhosphorylationDKEVGDGTTSVVIIA
CCCCCCCHHHHHHHH
22.1930622161
91PhosphorylationKEVGDGTTSVVIIAA
CCCCCCHHHHHHHHH
25.6730622161
92PhosphorylationEVGDGTTSVVIIAAE
CCCCCHHHHHHHHHH
17.7730622161
109UbiquitinationKNADELVKQKIHPTS
HCHHHHHHCCCCCCC
59.5021906983
1092-HydroxyisobutyrylationKNADELVKQKIHPTS
HCHHHHHHCCCCCCC
59.50-
109AcetylationKNADELVKQKIHPTS
HCHHHHHHCCCCCCC
59.5025953088
111UbiquitinationADELVKQKIHPTSVI
HHHHHHCCCCCCCHH
36.9521906983
1112-HydroxyisobutyrylationADELVKQKIHPTSVI
HHHHHHCCCCCCCHH
36.95-
115PhosphorylationVKQKIHPTSVISGYR
HHCCCCCCCHHCHHH
22.8223186163
116PhosphorylationKQKIHPTSVISGYRL
HCCCCCCCHHCHHHH
23.1623186163
119PhosphorylationIHPTSVISGYRLACK
CCCCCHHCHHHHHHH
27.8420068231
121PhosphorylationPTSVISGYRLACKEA
CCCHHCHHHHHHHHH
8.8220068231
126UbiquitinationSGYRLACKEAVRYIN
CHHHHHHHHHHHHHH
43.0021906983
1262-HydroxyisobutyrylationSGYRLACKEAVRYIN
CHHHHHHHHHHHHHH
43.00-
131PhosphorylationACKEAVRYINENLIV
HHHHHHHHHHHCCEE
11.0828152594
147S-nitrosocysteineTDELGRDCLINAAKT
HHHHCHHHHHHHHHH
3.86-
147S-nitrosylationTDELGRDCLINAAKT
HHHHCHHHHHHHHHH
3.8622178444
147S-palmitoylationTDELGRDCLINAAKT
HHHHCHHHHHHHHHH
3.8626865113
153UbiquitinationDCLINAAKTSMSSKI
HHHHHHHHHCCCCCC
38.43-
1532-HydroxyisobutyrylationDCLINAAKTSMSSKI
HHHHHHHHHCCCCCC
38.43-
153AcetylationDCLINAAKTSMSSKI
HHHHHHHHHCCCCCC
38.4325953088
157PhosphorylationNAAKTSMSSKIIGIN
HHHHHCCCCCCCCCC
28.39-
158PhosphorylationAAKTSMSSKIIGING
HHHHCCCCCCCCCCC
21.16-
181PhosphorylationDAVLAIKYTDIRGQP
HHHHEEEEECCCCCC
11.9728152594
182PhosphorylationAVLAIKYTDIRGQPR
HHHEEEEECCCCCCC
21.6828152594
185MethylationAIKYTDIRGQPRYPV
EEEEECCCCCCCCCC
40.27-
190PhosphorylationDIRGQPRYPVNSVNI
CCCCCCCCCCCHHHH
20.4428152594
194PhosphorylationQPRYPVNSVNILKAH
CCCCCCCHHHHHHHC
19.4423312004
199MethylationVNSVNILKAHGRSQM
CCHHHHHHHCCHHHH
34.2419608861
199AcetylationVNSVNILKAHGRSQM
CCHHHHHHHCCHHHH
34.2419608861
199UbiquitinationVNSVNILKAHGRSQM
CCHHHHHHHCCHHHH
34.2419608861
199MalonylationVNSVNILKAHGRSQM
CCHHHHHHHCCHHHH
34.2426320211
204PhosphorylationILKAHGRSQMESMLI
HHHHCCHHHHHHHHH
38.1725072903
208PhosphorylationHGRSQMESMLISGYA
CCHHHHHHHHHHHHH
17.3426126808
212PhosphorylationQMESMLISGYALNCV
HHHHHHHHHHHHHCC
23.0725072903
214PhosphorylationESMLISGYALNCVVG
HHHHHHHHHHHCCCC
10.9225072903
218GlutathionylationISGYALNCVVGSQGM
HHHHHHHCCCCCCCC
2.4622555962
222PhosphorylationALNCVVGSQGMPKRI
HHHCCCCCCCCCHHH
16.3825072903
227AcetylationVGSQGMPKRIVNAKI
CCCCCCCHHHHCCEE
45.9526051181
233UbiquitinationPKRIVNAKIACLDFS
CHHHHCCEEEEEEHH
26.15-
233AcetylationPKRIVNAKIACLDFS
CHHHHCCEEEEEEHH
26.1525953088
236S-nitrosocysteineIVNAKIACLDFSLQK
HHCCEEEEEEHHCHH
4.22-
236GlutathionylationIVNAKIACLDFSLQK
HHCCEEEEEEHHCHH
4.2222555962
236S-nitrosylationIVNAKIACLDFSLQK
HHCCEEEEEEHHCHH
4.2219483679
240PhosphorylationKIACLDFSLQKTKMK
EEEEEEHHCHHCCCC
29.5625159151
243UbiquitinationCLDFSLQKTKMKLGV
EEEHHCHHCCCCCCE
56.24-
2432-HydroxyisobutyrylationCLDFSLQKTKMKLGV
EEEHHCHHCCCCCCE
56.24-
243AcetylationCLDFSLQKTKMKLGV
EEEHHCHHCCCCCCE
56.2425953088
245AcetylationDFSLQKTKMKLGVQV
EHHCHHCCCCCCEEE
40.86-
245UbiquitinationDFSLQKTKMKLGVQV
EHHCHHCCCCCCEEE
40.86-
247UbiquitinationSLQKTKMKLGVQVVI
HCHHCCCCCCEEEEE
43.58-
255PhosphorylationLGVQVVITDPEKLDQ
CCEEEEECCHHHHHH
33.6123532336
259AcetylationVVITDPEKLDQIRQR
EEECCHHHHHHHHHH
63.8525953088
259UbiquitinationVVITDPEKLDQIRQR
EEECCHHHHHHHHHH
63.8521906983
268PhosphorylationDQIRQRESDITKERI
HHHHHHCCHHCHHHH
36.1822210691
296GlutathionylationTGGIDDMCLKYFVEA
CCCHHHHHHHHHHHH
3.6922555962
299PhosphorylationIDDMCLKYFVEAGAM
HHHHHHHHHHHHHHH
10.4219534553
306SulfoxidationYFVEAGAMAVRRVLK
HHHHHHHHHHHHHHH
3.2930846556
344SulfoxidationEETFEAAMLGQAEEV
HHHHHHHHHCCHHHH
5.7928183972
357S-nitrosocysteineEVVQERICDDELILI
HHHHHHCCCCEEEEE
7.26-
357GlutathionylationEVVQERICDDELILI
HHHHHHCCCCEEEEE
7.2622555962
357S-nitrosylationEVVQERICDDELILI
HHHHHHCCCCEEEEE
7.2618335467
365AcetylationDDELILIKNTKARTS
CCEEEEEECCCCCCC
55.9323749302
365UbiquitinationDDELILIKNTKARTS
CCEEEEEECCCCCCC
55.93-
3652-HydroxyisobutyrylationDDELILIKNTKARTS
CCEEEEEECCCCCCC
55.93-
367PhosphorylationELILIKNTKARTSAS
EEEEEECCCCCCCCH
22.5323898821
368UbiquitinationLILIKNTKARTSASI
EEEEECCCCCCCCHH
45.31-
371PhosphorylationIKNTKARTSASIILR
EECCCCCCCCHHHHC
33.2421406692
372PhosphorylationKNTKARTSASIILRG
ECCCCCCCCHHHHCC
17.9221406692
374PhosphorylationTKARTSASIILRGAN
CCCCCCCHHHHCCCC
15.2121406692
384SulfoxidationLRGANDFMCDEMERS
HCCCCCHHCHHHHHH
2.9121406390
385GlutathionylationRGANDFMCDEMERSL
CCCCCHHCHHHHHHH
3.9622555962
388SulfoxidationNDFMCDEMERSLHDA
CCHHCHHHHHHHHHH
3.1130846556
397S-nitrosocysteineRSLHDALCVVKRVLE
HHHHHHHHHHHHHHH
3.38-
397GlutathionylationRSLHDALCVVKRVLE
HHHHHHHHHHHHHHH
3.3822555962
397S-nitrosylationRSLHDALCVVKRVLE
HHHHHHHHHHHHHHH
3.3819483679
400AcetylationHDALCVVKRVLESKS
HHHHHHHHHHHHCCC
19.1819608861
400UbiquitinationHDALCVVKRVLESKS
HHHHHHHHHHHHCCC
19.1819608861
4002-HydroxyisobutyrylationHDALCVVKRVLESKS
HHHHHHHHHHHHCCC
19.18-
400MalonylationHDALCVVKRVLESKS
HHHHHHHHHHHHCCC
19.1826320211
405PhosphorylationVVKRVLESKSVVPGG
HHHHHHHCCCCCCCC
26.5222210691
422PhosphorylationVEAALSIYLENYATS
HHHHHHHHHHHHHHC
12.4622210691
428PhosphorylationIYLENYATSMGSREQ
HHHHHHHHCCCCHHH
14.6422210691
429PhosphorylationYLENYATSMGSREQL
HHHHHHHCCCCHHHH
16.9924275569
443MethylationLAIAEFARSLLVIPN
HHHHHHHHHHCCCCC
32.91-
444PhosphorylationAIAEFARSLLVIPNT
HHHHHHHHHCCCCCH
23.7221712546
460PhosphorylationAVNAAQDSTDLVAKL
HHCCCCCCHHHHHHH
16.2521712546
466UbiquitinationDSTDLVAKLRAFHNE
CCHHHHHHHHHHHHH
30.9021906983
466AcetylationDSTDLVAKLRAFHNE
CCHHHHHHHHHHHHH
30.9023236377
468MethylationTDLVAKLRAFHNEAQ
HHHHHHHHHHHHHHC
34.20-
481UbiquitinationAQVNPERKNLKWIGL
HCCCCCCCCCEEEEE
66.04-
484AcetylationNPERKNLKWIGLDLS
CCCCCCCEEEEEECC
46.2723749302
484UbiquitinationNPERKNLKWIGLDLS
CCCCCCCEEEEEECC
46.2721890473
491PhosphorylationKWIGLDLSNGKPRDN
EEEEEECCCCCCCCC
43.1128450419
494AcetylationGLDLSNGKPRDNKQA
EEECCCCCCCCCCCC
40.9226051181
494UbiquitinationGLDLSNGKPRDNKQA
EEECCCCCCCCCCCC
40.9221890473
494MalonylationGLDLSNGKPRDNKQA
EEECCCCCCCCCCCC
40.9226320211
499UbiquitinationNGKPRDNKQAGVFEP
CCCCCCCCCCCCCCC
45.90-
4992-HydroxyisobutyrylationNGKPRDNKQAGVFEP
CCCCCCCCCCCCCCC
45.90-
499MalonylationNGKPRDNKQAGVFEP
CCCCCCCCCCCCCCC
45.9026320211
499AcetylationNGKPRDNKQAGVFEP
CCCCCCCCCCCCCCC
45.9025953088
510UbiquitinationVFEPTIVKVKSLKFA
CCCCEEEEEECCCCH
39.84-
510AcetylationVFEPTIVKVKSLKFA
CCCCEEEEEECCCCH
39.8425953088
512UbiquitinationEPTIVKVKSLKFATE
CCEEEEEECCCCHHH
44.33-
513PhosphorylationPTIVKVKSLKFATEA
CEEEEEECCCCHHHH
39.5224719451
515UbiquitinationIVKVKSLKFATEAAI
EEEEECCCCHHHHHH
39.79-
532AcetylationLRIDDLIKLHPESKD
EEHHHHHHHCCCCCC
48.3023954790
532UbiquitinationLRIDDLIKLHPESKD
EEHHHHHHHCCCCCC
48.3021890473
5322-HydroxyisobutyrylationLRIDDLIKLHPESKD
EEHHHHHHHCCCCCC
48.30-
532MalonylationLRIDDLIKLHPESKD
EEHHHHHHHCCCCCC
48.3026320211
537PhosphorylationLIKLHPESKDDKHGS
HHHHCCCCCCCCCCC
45.9223401153
538AcetylationIKLHPESKDDKHGSY
HHHCCCCCCCCCCCH
69.1823749302
538UbiquitinationIKLHPESKDDKHGSY
HHHCCCCCCCCCCCH
69.1821906983
541AcetylationHPESKDDKHGSYEDA
CCCCCCCCCCCHHHH
61.0623954790
541UbiquitinationHPESKDDKHGSYEDA
CCCCCCCCCCCHHHH
61.0621890473
5412-HydroxyisobutyrylationHPESKDDKHGSYEDA
CCCCCCCCCCCHHHH
61.06-
541MalonylationHPESKDDKHGSYEDA
CCCCCCCCCCCHHHH
61.0626320211
544PhosphorylationSKDDKHGSYEDAVHS
CCCCCCCCHHHHHHH
25.6822167270
545PhosphorylationKDDKHGSYEDAVHSG
CCCCCCCHHHHHHHC
23.5522167270
551PhosphorylationSYEDAVHSGALND--
CHHHHHHHCCCCC--
21.1125159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TCPA_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TCPA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TCPA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TCPB_HUMANCCT2physical
16085932
TCPG_HUMANCCT3physical
16085932
TCPD_HUMANCCT4physical
16085932
TCPE_HUMANCCT5physical
16085932
TCPZ_HUMANCCT6Aphysical
16085932
TCPH_HUMANCCT7physical
16085932
TCPQ_HUMANCCT8physical
16085932
GLCM_HUMANGBAphysical
21098288
VHL_HUMANVHLphysical
14636579
PACRG_HUMANPACRGphysical
14532270
TCPB_HUMANCCT2physical
14532270
TCPE_HUMANCCT5physical
22939629
TCPH_HUMANCCT7physical
22939629
TCPB_HUMANCCT2physical
22939629
TCPD_HUMANCCT4physical
22939629
TCPG_HUMANCCT3physical
22939629
TCPZ_HUMANCCT6Aphysical
22939629
TCPQ_HUMANCCT8physical
22939629
TCPW_HUMANCCT6Bphysical
22939629
TCPG_HUMANCCT3physical
22863883
PP4C_HUMANPPP4Cphysical
22863883
VRK2_HUMANVRK2physical
24298020
MTG8R_HUMANCBFA2T2physical
25416956
TCPB_HUMANCCT2physical
26344197
TCPH_HUMANCCT7physical
26344197
TCPQ_HUMANCCT8physical
26344197
RPN1_HUMANRPN1physical
26344197
QCR2_HUMANUQCRC2physical
26344197
ACTB_HUMANACTBphysical
14532270

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TCPA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides.";
Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.;
Nat. Biotechnol. 21:566-569(2003).
Cited for: PROTEIN SEQUENCE OF 1-11, AND ACETYLATION AT MET-1.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199; LYS-400 AND LYS-532,AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-400, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND SER-551, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-299, AND MASSSPECTROMETRY.

TOP